LDL-Cholesterol Targets After the ACC/AHA 2013 Guidelines Evidence That Lower Is Better?

被引：5
作者：
Ben-Yehuda, Ori [1 ]
DeMaria, Anthony N. [2 ]
机构：
[1] Cardiovascu Res Fdn, New York, NY 10022 USA
[2] Univ Calif San Diego, Dept Med, San Diego, CA 92103 USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2014年 / 64卷 / 05期
关键词：
guidelines; LDL-cholesterol; LDL-cholesterol goal; statins; DENSITY-LIPOPROTEIN CHOLESTEROL; EVENTS; STATIN; MONOTHERAPY; REDUCTION; EFFICACY; RISK;
D O I：
10.1016/j.jacc.2014.05.020
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：495 / 497
页数：3
相关论文
共 15 条
  • [1] [Anonymous], 1988, ARCH INTERN MED, V148, P1023
  • [2] Influence of low high-density lipoprotein cholesterol and elevated triglyceride on coronary heart disease events and response to simvastatin therapy in 4S
    Ballantyne, CM
    Olsson, AG
    Cook, TJ
    Mercuri, MF
    Pedersen, TR
    Kjekshus, J
    [J]. CIRCULATION, 2001, 104 (25) : 3046 - 3051
  • [3] Missense mutations in the PCSK9 gene are associated with hypocholesterolemia and possibly increased response to statin therapy
    Berge, KE
    Ose, L
    Leren, TP
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2006, 26 (05) : 1094 - 1100
  • [4] Very Low Levels of Atherogenic Lipoproteins and the Risk for Cardiovascular Events A Meta-Analysis of Statin Trials
    Boekholdt, S. Matthijs
    Hovingh, G. Kees
    Mora, Samia
    Arsenault, Benoit J.
    Amarenco, Pierre
    Pedersen, Terje R.
    LaRosa, John C.
    Waters, David D.
    DeMicco, David A.
    Simes, R. John
    Keech, Antony C.
    Colquhoun, David
    Hitman, Graham A.
    Betteridge, John
    Clearfield, Michael B.
    Downs, John R.
    Colhoun, Helen M.
    Gotto, Antonio M., Jr.
    Ridker, Paul M.
    Grundy, Scott M.
    Kastelein, John J. P.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 64 (05) : 485 - 494
  • [5] Rationale and design of IMPROVE-IT (IMProved Reduction of Outcomes: Vytorin Efficacy International Trial): Comparison of ezetimbe/simvastatin versus simvastatin monotherapy on cardiovascular outcomes in patients with acute coronary syndromes
    Cannon, Christopher P.
    Giugliano, Robert P.
    Blazing, Michael A.
    Harrington, Robert A.
    Peterson, John L.
    Sisk, Christine McCrary
    Strony, John
    Musliner, Thomas A.
    McCabe, Carolyn H.
    Veltri, Enrico
    Braunwald, Eugene
    Califf, Robert M.
    [J]. AMERICAN HEART JOURNAL, 2008, 156 (05) : 826 - 832
  • [6] Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)
    Cleeman, JI
    Grundy, SM
    Becker, D
    Clark, LT
    Cooper, RS
    Denke, MA
    Howard, WJ
    Hunninghake, DB
    Illingworth, DR
    Luepker, RV
    McBride, P
    McKenney, JM
    Pasternak, RC
    Stone, NJ
    Van Horn, L
    Brewer, HB
    Ernst, ND
    Gordon, D
    Levy, D
    Rifkind, B
    Rossouw, JE
    Savage, P
    Haffner, SM
    Orloff, DG
    Proschan, MA
    Schwartz, JS
    Sempos, CT
    Shero, ST
    Murray, EZ
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19): : 2486 - 2497
  • [7] Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels - Results of AFCAPS/TexCAPS
    Downs, JR
    Clearfield, M
    Weis, S
    Whitney, E
    Shapiro, DR
    Beere, PA
    Langendorfer, A
    Stein, EA
    Kruyer, W
    Gotto, AM
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 279 (20): : 1615 - 1622
  • [8] Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines
    Grundy, SM
    Cleeman, JI
    Merz, CNB
    Brewer, HB
    Clark, LT
    Hunninghake, DB
    Pasternak, RC
    Smith, SC
    Stone, NJ
    [J]. CIRCULATION, 2004, 110 (02) : 227 - 239
  • [9] Cardiovascular Event Reduction and Adverse Events Among Subjects Attaining Low-Density Lipoprotein Cholesterol <50 mg/dl With Rosuvastatin
    Hsia, Judith
    MacFadyen, Jean G.
    Monyak, John
    Ridker, Paul M.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2011, 57 (16) : 1666 - 1675
  • [10] Lipid-altering efficacy of ezetimibe plus statin and statin monotherapy and identification of factors associated with treatment response: A pooled analysis of over 21,000 subjects from 27 clinical trials
    Morrone, Doralisa
    Weintraub, William S.
    Toth, Peter P.
    Hanson, Mary E.
    Lowe, Robert S.
    Lin, Jianxin
    Shah, Arvind K.
    Tershakovec, Andrew M.
    [J]. ATHEROSCLEROSIS, 2012, 223 (02) : 251 - 261
12